These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 6000667)
21. [Peptic ulcer and gastritis in the time of Helicobacter pylori]. Ann Gastroenterol Hepatol (Paris); 1996; 32(1):25-34. PubMed ID: 8669805 [No Abstract] [Full Text] [Related]
22. [Therapy of gastritis, stomach ulcer and duodenal ulcer. I]. Schultis K Med Welt; 1970 Jan; 3():104-6. PubMed ID: 5444208 [No Abstract] [Full Text] [Related]
23. [The characteristics of duodenogastric reflux in peptic ulcer and chronic gastritis]. Danilov AS; Reshetnikov OV; Kurilovich SA Ter Arkh; 1994; 66(2):43-5. PubMed ID: 8160143 [TBL] [Abstract][Full Text] [Related]
24. [Pulmonary tuberculosis associated with diseases of the digestive organs]. Savula MM; Grishchuk LA Probl Tuberk; 1985; (6):35-9. PubMed ID: 4048122 [No Abstract] [Full Text] [Related]
26. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure. Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780 [TBL] [Abstract][Full Text] [Related]
27. [Cancerous degeneration of gastritis and peptic ulcer]. Ulker M Rev Med Moyen Orient; 1967; 24(2):153-4. PubMed ID: 5248418 [No Abstract] [Full Text] [Related]
29. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
30. [The use of cholinolytic preparations in the treatment of patients with peptic ulcer and chronic gastritis]. Fishzon-Ryss IuI Voen Med Zh; 1965 May; 5():58-63. PubMed ID: 4380574 [No Abstract] [Full Text] [Related]
31. Campylobacter pylori: new and renewed insights into gastritis-associated ulcer disease (GAUD). Börsch G Hepatogastroenterology; 1987 Oct; 34(5):191-3. PubMed ID: 3315920 [No Abstract] [Full Text] [Related]
32. [Contribution to the problem of causal relationships between ulcer disease, gastritis and liver damage]. Kuss B; Mehrabi V Med Welt; 1968 Mar; 13():818-22. PubMed ID: 5715691 [No Abstract] [Full Text] [Related]
33. [Effect of dimedrol on the function of the pancreas, gallbladder and pyloric valve in patients with peptic ulcer and chronic gastritis]. Smoligovets PV Vrach Delo; 1967; 9():30-2. PubMed ID: 5621773 [No Abstract] [Full Text] [Related]
34. [The effectiveness of 7-day combined Helicobacter eradication therapy in patients with peptic ulcer and chronic gastritis]. Grigor'ev PIa; Iakovenko EP; Talanova EV Klin Med (Mosk); 2001; 79(6):41-4. PubMed ID: 11521379 [TBL] [Abstract][Full Text] [Related]
35. [Problem of the relations between gastritis and ulcerous disease]. IAGNOV S; MAXIMILIAN V; MIRON C Probl Tuberculoza; 1957; 8():111-8. PubMed ID: 13554222 [No Abstract] [Full Text] [Related]
36. [Dilating gastritis with giant ulcer of the lesser curvature]. DARNAUD C; FERRET P; DENARD Y; VOISIN R; MOREAU G Arch Mal Appar Dig Mal Nutr; 1955 Mar; 44(3):383-4. PubMed ID: 14388854 [No Abstract] [Full Text] [Related]
37. [Incidence and clinical characteristics of associated diseases of the digestive organs]. Leshxhinskiĭ LA; Vakhrushev IaM Sov Med; 1980; (3):85-7. PubMed ID: 7376019 [No Abstract] [Full Text] [Related]
38. [Therapeutic use of vitamin U in gastroenterological practice]. Trusov VV; Vakhrushev IaM Vrach Delo; 1978 Oct; (10):101-4. PubMed ID: 716341 [No Abstract] [Full Text] [Related]
39. [Treatment of peptic ulcer and hyperacid gastritis with Gastramyl]. Bochenek WJ; Frydecka I; Lawińska B; Mazurek W; Swiderska-Blońska S Pol Tyg Lek; 1976 Feb; 31(8):327-8. PubMed ID: 1257149 [No Abstract] [Full Text] [Related]
40. [Therapy of some conditions of chronic gastroduodenitis and of gastroduodenal ulcer with a preparation, for intravenous or intramuscular injection or oral administration, derived from a carboxyl halicyclic acid]. Abbona C; Gatto PL; Bezante GC Minerva Med; 1967 Oct; 58(86):3691-9. PubMed ID: 6061063 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]